Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05511246 · ClinicalTrials.gov registry record · Phase 2

Venous Ethanol for Ventricular Tachycardia

A Phase 2 study of Ventricular Tachycardia and Ischemic Cardiomyopathy, sponsored by The Methodist Hospital Research Institute.

Recruiting
Registry status
Phase 2
Development phase
156
Enrollment target
1
Study location

NCT05511246 is a Phase 2 study of Ventricular Tachycardia and Ischemic Cardiomyopathy that is actively recruiting participants, run by The Methodist Hospital Research Institute. The registered enrollment target is 156 participants, below the 283-participant average among 28 other Ventricular Tachycardia trials with a reported enrollment target (45% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05511246, a Phase 2 study of Ventricular Tachycardia and Ischemic Cardiomyopathy, is actively recruiting participants, sponsored by The Methodist Hospital Research Institute.

RECRUITING
Registry status
Phase 2
Development phase
156 participants
Enrollment target
1
Study location

Study Summary

Comparative effectiveness randomized clinical trial, comparing endocardial radiofrequency ablation alone vs radiofrequency ablation combined with venous ethanol in patients with ischemic ventricular tachycardia -Venous Ethanol for Left Ventricular Ischemic Ventricular Tachycardia -VELVET clinical trial

Conditions Studied

Ventricular Tachycardia Ischemic Cardiomyopathy

Interventions

  • DRUG Venous ethanol
  • PROCEDURE Catheter ablation

Study Locations (1)

Texas

  • Houston Methodist Hospital - Houston

Trial Details

FieldValue
Enrollment Target 156 participants
Start Date 2023-04-12
Est. Completion 2028-12-12
Phase Phase 2

Sponsor

The Methodist Hospital Research Institute

126 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT05511246

The ClinicalTrials.gov registry entry for NCT05511246 describes a study currently listed as recruiting, categorized as Phase 2. The registered enrollment target is 156 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 283-participant average among 28 other Ventricular Tachycardia trials with a reported enrollment target (45% lower). The listed sponsor is The Methodist Hospital Research Institute, which has 126 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Ventricular Tachycardia appearing as the primary indexed condition, and to 2 interventions - of which Venous ethanol is the first listed.

NCT05511246 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.

Frequently Asked Questions

What is clinical trial NCT05511246 about?

NCT05511246 is a clinical study titled "Venous Ethanol for Ventricular Tachycardia". Comparative effectiveness randomized clinical trial, comparing endocardial radiofrequency ablation alone vs radiofrequency ablation combined with venous ethanol in patients with ischemic ventricular tachycardia -Venous Ethanol for Left Ventricular Ischemic Ventricular Tachycardia -VELVET clinical tr...

What is the current status of trial NCT05511246?

This trial is currently recruiting. It is a Phase 2 study. The enrollment target is 156 participants. The study started on 2023-04-12. Estimated completion is 2028-12-12.

What conditions does trial NCT05511246 study?

This clinical trial studies the following conditions: Ventricular Tachycardia, Ischemic Cardiomyopathy.

What interventions are being tested in trial NCT05511246?

The interventions under investigation include: Venous ethanol (DRUG), Catheter ablation (PROCEDURE).

Who is sponsoring clinical trial NCT05511246?

This trial is sponsored by The Methodist Hospital Research Institute, which has 126 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05511246 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Ventricular Tachycardia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Ventricular Tachycardia

All registered trials for this condition

Ischemic Cardiomyopathy

All registered trials for this condition

Texas

All trials with a study site in Texas

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.